{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
SOPHiA GENETICS SA
SOPHiA GENETICS SA Hits New 52-Week High at USD 5.30
SOPHiA GENETICS SA achieved a new 52-week high of USD 5.30 on October 30, 2025, significantly up from its low of USD 2.58. With a market cap of USD 224 million, the company operates at a loss and has a negative return on equity, indicating challenges in the competitive software industry.
Is SOPHiA GENETICS SA technically bullish or bearish?
As of September 2, 2025, SOPHiA GENETICS SA shows mixed technical signals with a mildly bullish short-term trend but has underperformed the S&P 500 significantly over the past year and three years.
Is SOPHiA GENETICS SA technically bullish or bearish?
As of June 3, 2025, the market trend is mildly bearish, influenced by bearish daily moving averages and weekly Bollinger Bands, despite some bullish signals from the MACD and KST, with the Dow Theory showing mixed trends and the RSI indicating no momentum.
What does SOPHiA GENETICS SA do?
SOPHiA GENETICS SA is a micro-cap software company specializing in data-driven medicine, with recent net sales of $18 million and a net loss of $17 million. The company has a market cap of $195.15 million and does not pay dividends.
How big is SOPHiA GENETICS SA?
As of Jun 18, SOPHiA GENETICS SA has a market capitalization of 195.15 million, with net sales of 67.17 million and a net profit of -66.18 million over the latest four quarters. As of Dec 24, shareholder's funds are 96.49 million and total assets are 156.41 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
